1-17 of 17
Jennifer L. Sherr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study

Darrell M. Wilson, Susan L. Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe, David Scheinker, Andrea K. Steck, Madhuri M. Vasudevan, Siripoom V. McKay, Jennifer L. Sherr, Kevan C. Herold, Jessica L. Dunne, Carla J. Greenbaum, Sandra M. Lord, Michael J. Haller, Desmond A. Schatz, Mark A. Atkinson, Patrick W. Nelson, Massimo Pietropaolo, the Type 1 Diabetes TrialNet Study Group
Journal: Diabetes Care
Diabetes Care 2023;46(3):526–534
https://doi.org/10.2337/dc22-1297
Published: 02 February 2023
View article titled, CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study
Open the PDF for CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study in another window
Journal Articles

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Jennifer L. Sherr, Lutz Heinemann, G. Alexander Fleming, Richard M. Bergenstal, Daniela Bruttomesso, Hélène Hanaire, Reinhard W. Holl, John R. Petrie, Anne L. Peters, Mark Evans
Journal: Diabetes Care
Diabetes Care 2022;45(12):3058–3074
https://doi.org/10.2337/dci22-0018
Published: 06 October 2022
View article titled, Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association
Open the PDF for Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association in another window
Journal Articles

Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial

Jennifer L. Sherr, Bruce W. Bode, Gregory P. Forlenza, Lori M. Laffel, Melissa J. Schoelwer, Bruce A. Buckingham, Amy B. Criego, Daniel J. DeSalvo, Sarah A. MacLeish, David W. Hansen, Trang T. Ly
Journal: Diabetes Care
Diabetes Care 2022;45(8):1907–1910
https://doi.org/10.2337/dc21-2359
Published: 26 July 2022
View article titled, Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial
Open the PDF for Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial in another window
Journal Articles

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Sue A. Brown, Gregory P. Forlenza, Bruce W. Bode, Jordan E. Pinsker, Carol J. Levy, Amy B. Criego, David W. Hansen, Irl B. Hirsch, Anders L. Carlson, Richard M. Bergenstal, Jennifer L. Sherr, Sanjeev N. Mehta, Lori M. Laffel, Viral N. Shah, Anuj Bhargava, Ruth S. Weinstock, Sarah A. MacLeish, Daniel J. DeSalvo, Thomas C. Jones, Grazia Aleppo, Bruce A. Buckingham, Trang T. Ly, Omnipod 5 Research Group, Sue A. Brown, Mary Voelmle, Emma Emory, Gregory P. Forlenza, R. Paul Wadwa, Robert Slover, Erin Cobry, Laurel H. Messer, Cari Berget, Susan McCoy, Viral N. Shah, Halis K. Akturk, Nicole Schneider, Hal Joseph, Prakriti Joshee, Christie Beatson, Bruce W. Bode, Brooke Narron, Tricia Lopez, Jordan E. Pinsker, Mei Mei Church, Kristin Castorino, Molly Piper, Jimena Perez, Carol J. Levy, David W. Lam, Camilla Levister, Grenye O’Malley, Selassie Ogyaadu, Dushyanthy Arasaratnam, Mitchell Plesser, Emily Nosova, Suzan Bzdick, David W. Hansen, Sheri L. Stone, Ruth S. Weinstock, Irl B. Hirsch, Subbulaxmi Trikudanathan, Nancy Sanborn, Dori Khakpour, Anders L. Carlson, Amy B. Criego, Richard M. Bergenstal, Thomas Martens, Aimee Grieme, Jamie Hyatt, Alina Punel, Diane Whipple, Jennifer L. Sherr, Michelle Van Name, Michelle Brei, Melinda Zgorski, Amy Steffen, Lori Carria, Sanjeev N. Mehta, Lori M. Laffel, Lindsay Roethke, Margaret Fisher, Rebecca Ortiz La Banca, Lisa Volkening, Louise Ambler-Osborn, Christine Turcotte, Emily F. Freiner, Anuj Bhargava, Lisa Borg, Sarah A. MacLeish, Jamie R. Wood, Beth A. Kaminski, Terri L. Casey, Wendy Campbell, Daniel J. DeSalvo, Siripoom McKay, Mary Kylie DeLaO, Carolina Villegas, Thomas C. Jones, Barry Russel Johns, Ashwini Gore, Leslie Harvill, Kayla Merritt, Jennifer Stanfield, Jennifer Sheldon, Lisa Hichkad, Erica Burnett, Alicia Castelot, Lindsay Bounds, Kaitlyn Preston, Rebecca Goldfaden, Grazia Aleppo, Jelena Kravarusic, Anupam Bansal, Bruce A. Buckingham, Laya Ekhlaspour, Ryan Kingman, Kaisa Kivilaid, Krista Kleve, Trang T. Ly, Bonnie Dumais, Todd Vienneau, Lauren M. Huyett, Joon Bok Lee, Jason O’Connor, Eric Benjamin
Journal: Diabetes Care
Diabetes Care 2021;44(7):1630–1640
https://doi.org/10.2337/dc21-0172
Published: 20 July 2021
View article titled, Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Open the PDF for Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes in another window
Journal Articles

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes

Irl B. Hirsch, Jennifer L. Sherr, Korey K. Hood
Journal: Diabetes Care
Diabetes Care 2019;42(3):345–348
https://doi.org/10.2337/dci18-0040
Published: 12 February 2019
View article titled, Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes
Open the PDF for Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes in another window
Journal Articles

Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults

Jennifer L. Sherr
Journal: Diabetes Care
Diabetes Care 2018;41(8):1572–1578
https://doi.org/10.2337/dci18-0003
Published: 23 June 2018
View article titled, Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults
Open the PDF for Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults in another window
Journal Articles

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System

Laurel H. Messer, Gregory P. Forlenza, Jennifer L. Sherr, R. Paul Wadwa, Bruce A. Buckingham, Stuart A. Weinzimer, David M. Maahs, Robert H. Slover
Journal: Diabetes Care
Diabetes Care 2018;41(4):789–796
https://doi.org/10.2337/dc17-1682
Published: 14 February 2018
View article titled, Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System
Open the PDF for Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System in another window
Includes: Supplementary data
Journal Articles

No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year

Jennifer L. Sherr, Claire T. Boyle, Kellee M. Miller, Roy W. Beck, William V. Tamborlane
Journal: Diabetes Care
Diabetes Care 2016;39(12):e214–e215
https://doi.org/10.2337/dc16-1522
Published: 04 October 2016
View article titled, No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year
Open the PDF for No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year in another window
Journal Articles

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270

Michael R. Rickels, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Hélène Dulude, Jennifer L. Sherr, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio, R. Paul Wadwa, Andrew J. Ahmann, Michael J. Haller, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck
Journal: Diabetes Care
Diabetes Care 2016;39(10):e193–e194
https://doi.org/10.2337/dci16-0025
Published: 13 September 2016
View article titled, Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270
Open the PDF for Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270 in another window
Journal Articles

Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide

Jennifer L. Sherr, Neha S. Patel, Camille I. Michaud, Miladys M. Palau-Collazo, Michelle A. Van Name, William V. Tamborlane, Eda Cengiz, Lori R. Carria, Eileen M. Tichy, Stuart A. Weinzimer
Journal: Diabetes Care
Diabetes Care 2016;39(7):1127–1134
https://doi.org/10.2337/dc16-0089
Published: 11 April 2016
View article titled, Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide
Open the PDF for Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide in another window
Journal Articles

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

Jennifer L. Sherr, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Hélène Dulude, Michael R. Rickels, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio, Larry A. Fox, R. Paul Wadwa, Desmond A. Schatz, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck, for the T1D Exchange Intranasal Glucagon Investigators
Journal: Diabetes Care
Diabetes Care 2016;39(4):555–562
https://doi.org/10.2337/dc15-1606
Published: 16 February 2016
View article titled, Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
Open the PDF for Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Michael R. Rickels, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Hélène Dulude, Jennifer L. Sherr, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio, R. Paul Wadwa, Andrew J. Ahmann, Michael J. Haller, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck
Journal: Diabetes Care
Diabetes Care 2016;39(2):264–270
https://doi.org/10.2337/dc15-1498
Published: 17 December 2015
View article titled, Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study
Open the PDF for Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study in another window
Includes: Supplementary data
Journal Articles

Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose

Jennifer L. Sherr, Miladys Palau Collazo, Eda Cengiz, Camille Michaud, Lori Carria, Amy T. Steffen, Kate Weyman, Melinda Zgorski, Eileen Tichy, William V. Tamborlane, Stuart A. Weinzimer
Journal: Diabetes Care
Diabetes Care 2014;37(3):773–779
https://doi.org/10.2337/dc13-1608
Published: 11 February 2014
View article titled, Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose
Open the PDF for Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose in another window
Journal Articles

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges

Tara Ghazi, Linda Rink, Jennifer L. Sherr, Kevan C. Herold
Journal: Diabetes Care
Diabetes Care 2014;37(1):210–216
https://doi.org/10.2337/dc13-1169
Published: 11 December 2013
View article titled, Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges
Open the PDF for Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges in another window
Journal Articles

Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes

Jennifer L. Sherr, MD, Eda Cengiz, MD, Cesar C. Palerm, PHD, Bud Clark, MA, Natalie Kurtz, PHD, Anirban Roy, PHD, Lori Carria, BS, Martin Cantwell, BSC, William V. Tamborlane, MD, Stuart A. Weinzimer, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):2909–2914
https://doi.org/10.2337/dc13-0010
Published: 14 September 2013
View article titled, Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes
Open the PDF for Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes

Stuart A. Weinzimer, MD, Jennifer L. Sherr, MD, Eda Cengiz, MD, Grace Kim, MD, Jessica L. Ruiz, Lori Carria, BS, Gayane Voskanyan, PHD, Anirban Roy, PHD, William V. Tamborlane, MD
Journal: Diabetes Care
Diabetes Care 2012;35(10):1994–1999
https://doi.org/10.2337/dc12-0330
Published: 11 September 2012
View article titled, Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
Open the PDF for Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

The Alteration of Aspart Insulin Pharmacodynamics When Mixed With Detemir Insulin

Eda Cengiz, MD, Karena L. Swan, MD, William V. Tamborlane, MD, Jennifer L. Sherr, MD, Melody Martin, CRA, Stuart A. Weinzimer, MD
Journal: Diabetes Care
Diabetes Care 2012;35(4):690–692
https://doi.org/10.2337/dc11-0732
Published: 13 March 2012
View article titled, The Alteration of Aspart Insulin Pharmacodynamics When Mixed With Detemir Insulin
Open the PDF for The Alteration of Aspart Insulin Pharmacodynamics When Mixed With Detemir Insulin in another window